FDA Toughens Stance On OTC, Prescription Pain Relievers
The U.S. Food and Drug Administration on Thursday said it has strengthened warning requirements for nonsteroidal anti-inflammatory drugs, which now must carry more specific labels regarding increased risk of heart attack...To view the full article, register now.
Already a subscriber? Click here to view full article